{"name":"MSI Methylation Sciences, Inc.","slug":"msi-methylation-sciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxOQnVMZjBIMnRadVZZWkJTZGdNU3E0YkV6blU4ZTZwbEVuV09udVJvZDEzTFRmcjhjb1NhRDctNktxUHA1SmViU0xNYVNZejhOUS1XeFJVR3A2VzQ2MjAweE9EdHJJVzhMV0cxYUM0eF9CV0drVXhwbmQ2bHF2YzE5U2M5V0I5cUhtMXdFM1NjckE1dGhXR21uMzBfeWtaWEtkMkdkZnFZd1NDc3NldFFmVndCUEF3elRtNUJGMUpkLWF0UV9ITHpTOURBVS1KY3ZTN24tMWMzMlEyaGdVUXlLZ2JFRE5wWHhUODVFRGxfQlJTSXVkeTMtclBIbXVSQjJEdGxOSHFYdmxvRmtYUDN5RDdIY1NaRmZhQlpORm1oeXo1alRXbzh6SVUzT25SUlhWN3RXMkJJX1dFS2MyTF8wVjZzVGRqNkU?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire","summary":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight - PR Newswire","headline":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Dia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOZktDTlM4Nk1yU1A0R2RTNjEwMXZHZ1JjbzlURUV2X0s5bzA4RGhYNncwdzFxZm9kUHB2cHM2UjhUMzgzRk8tWE9GdnlLLUdoTm10eEhQSlNXYVRZQlpJZ2V6V3pWY0RlU0RjdUVTSVJUZmNabGxDVFpNZmdqMDh3dGFLbWRqbFNQQ3psak5WNA?oc=5","date":"2024-02-01","type":"pipeline","source":"Frontiers","summary":"Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression - Frontiers","headline":"Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBsWldBVEs2WnRjelF6QWxOSnRtaDRvM0I2ZVBEQlhfQ0N1cEEwenZUVkVqallYYlgwZEFsX3NfWW9ocnRYbkZkeURIYWlFa2F1Tl9UQlVUVnBWeDl2Zk5v?oc=5","date":"2023-12-14","type":"trial","source":"Nature","summary":"Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weighting | Translational Psy","headline":"Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNekp0aUdjTDBNeEVpV3EyYnlpcE5oa25OanlDSmtqT0dOT1ZibmRQWkROUXVLWmRsOU83eGpUdU9tclU4eS1pSkZkaEZHcUNpY3FldzBLd3h6ODdyaEVEUjllZ1c1UTZfWFNzdjFzdGo0ZmIwQ1FXM3ZGQ2kxS2thSTRQT0o4WFk?oc=5","date":"2018-04-26","type":"pipeline","source":"biv.com","summary":"European fortunes in forecast for B.C. pharma - biv.com","headline":"European fortunes in forecast for B.C. pharma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}